Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-Week Studies (ADvocate1 and ADvocate2)

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 151; no. 2; p. AB148
Main Authors Sher, Ellen, Boguniewicz, Mark, Golant, Alexandra, Zhong, Jinglin, Atwater, Amber Reck, Dawson, Zach, Siu, Kimberly, de Bruin-Weller, Marjolein, Carrascosa, Jose-Manuel, Thyssen, Jacob
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2023
Online AccessGet full text

Cover

More Information
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2022.12.463